Shots:
- Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized, single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome
- The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample, then generate libraries compatible with Illumina sequencing platforms
- The solution aims to accelerate research into COVID-19 prevention and treatment by enabling deeper and more holistic insights into the biology of SARS-CoV-2
Click here to read full press release/ article | Ref: Qiagen | Image: Euronews
